In alignment with the proteomics results, recent publications in Ryr2 KO mice have shown reduced expression of CSRP3 (22) and CSRP3 KO hESC-CMs exhibit a hypertrophic cardiomyopathy phenotype, with dysfunctional calcium handling (32). This evidence concerns the gene RYR2 and hypertrophic cardiomyopathy.